Reagent Kit for Detection of Mutations Associated with Cystic Fibrosis, Phenylketonuria, Galactosemia, and Non-Syndromic Sensorineural Hearing Loss by Real-Time PCR (MonogenScreen) – TU 21.20.23-105-46482062-2018

Reagent Kit for Detection of Mutations Associated with Cystic Fibrosis, Phenylketonuria, Galactosemia, and Non-Syndromic Sensorineural Hearing Loss by Real-Time PCR (MonogenScreen) – TU 21.20.23-105-46482062-2018

This reagent kit is intended for the identification of genetic mutations linked to cystic fibrosis, phenylketonuria, galactosemia, and non-syndromic sensorineural hearing loss using real-time PCR technology (MonogenScreen).

Kit Composition:

• Stream Amplification Mixes (16 variants) – 1 double strip (120 μl each)
• TechnoTaq MAX Polymerase – 2 vials (60 μl each)
• Stream PCR Buffer – 2 vials (600 μl each)
• DNA Dilution Buffer – 4 vials (1.0 ml each)
• Positive Control Sample – 2 vials (100 μl each)
• 8-well PCR Strips – 10 pieces
• Strip Caps – 2 pieces

This kit ensures precise and reproducible detection of the specified genetic mutations in human DNA samples.

If your organization wants to sell medical equipment, medical products or medical consumables in Russia, for example, Reagent Kit for Detection of Mutations Associated with Cystic Fibrosis, Phenylketonuria, Galactosemia, and Non-Syndromic Sensorineural Hearing Loss by Real-Time PCR (MonogenScreen) – TU 21.20.23-105-46482062-2018, then our information portal MEDCOMMERCE can help you with this. To do this, simply fill out the feedback form by clicking on the link FEEDBACK FORM.

The products posted on our website are approved for use in Russia by the state regulator Roszdravnadzor (Federal Service for Surveillance in Healthcare). The information is for informational purposes only.